1. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, Moses HL (2004) Breast Cancer Res 6(3): R215-31
    › Primary publication · 15084245 (PubMed) · PMC400675 (PubMed Central)
  2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA (2004) Laryngoscope 114(12): 2063-72
    › Primary publication · 15564824 (PubMed)
  3. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL (2003) Cancer Res 63(21): 7113-21
    › Primary publication · 14612504 (PubMed)
  4. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Matheny KE, Barbieri CE, Sniezek JC, Arteaga CL, Pietenpol JA (2003) Laryngoscope 113(6): 936-9
    › Primary publication · 12782800 (PubMed)
  5. Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. Barbieri CE, Barton CE, Pietenpol JA (2003) J Biol Chem 278(51): 51408-14
    › Primary publication · 14555649 (PubMed)
  6. Combined modality management of breast cancer: development of predictive markers through proteomics. Chakravarthy B, Pietenpol JA (2003) Semin Oncol 30(4 Suppl 9): 23-36
    › Primary publication · 12908134 (PubMed)
  7. Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins. Jo D, Lin Q, Nashabi A, Mays DJ, Unutmaz D, Pietenpol JA, Ruley HE (2003) J Cell Biochem 89(4): 674-87
    › Primary publication · 12858334 (PubMed)
  8. Analysis of cell-cycle checkpoint pathways in head and neck cancer cell lines: implications for therapeutic strategies. Coleman SC, Stewart ZA, Day TA, Netterville JL, Burkey BB, Pietenpol JA (2002) Arch Otolaryngol Head Neck Surg 128(2): 167-76
    › Primary publication · 11843726 (PubMed)
  9. Syk: a new player in the field of breast cancer. Stewart ZA, Pietenpol JA (2001) Breast Cancer Res 3(1): 5-7
    › Primary publication · 11250739 (PubMed) · PMC138668 (PubMed Central)
  10. p53 Signaling and cell cycle checkpoints. Stewart ZA, Pietenpol JA (2001) Chem Res Toxicol 14(3): 243-63
    › Primary publication · 11258974 (PubMed)